Pharmaceuticals Government Tenders in Moldova

Who buys pharmaceuticals in Moldova, what it is worth, how long you get to bid, and what is open today. Counted 2026-11-22.

36
Records tracked
4
Buying organizations
11
Open right now
29 days
Median response window

Registration, quality assurance and the shape of a medicines contract

A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programs -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.

Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.

The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and program funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.

This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.

Who buys pharmaceuticals in Moldova?

GlobalGov holds 36 pharmaceuticals records from 4 distinct buying organizations in Moldova. The most frequent publishers are Centrul Pentru Achiziții Publice Centralizate În Sănătate (15 records); Centrul pentru Achiziții Publice Centralizate în Sănătate (9 records); Centrul pentru Achiziţii Publice Centralizate în Sănătate (4 records); Centrul Pentru Achiziții Publice Centralizate ÎN Sănătate (1 record); Centrul pentru Achiziții Publice Centralizate în Sănătate (Centre for Centralized Public Procurement in Healthcare) (1 record); Serviciul Special pentru influenţe Active asupra Proceselor Hidrometeorologice (1 record). Between them the 6 largest account for 86% of everything published, so buying here is concentrated in a few authorities.

Buying organizationRecordsShare
Centrul Pentru Achiziții Publice Centralizate În Sănătate1542%
Centrul pentru Achiziții Publice Centralizate în Sănătate925%
Centrul pentru Achiziţii Publice Centralizate în Sănătate411%
Centrul Pentru Achiziții Publice Centralizate ÎN Sănătate12.8%
Centrul pentru Achiziții Publice Centralizate în Sănătate (Centre for Centralized Public Procurement in Healthcare)12.8%
Serviciul Special pentru influenţe Active asupra Proceselor Hidrometeorologice12.8%

What are pharmaceuticals contracts worth in Moldova?

30 of the 36 records publish a contract value. The median is $909,580 and the largest single published value is $4.9M. By size, 20 between $100k and $1M, 10 between $1M and $10M. The remaining 6 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.

Contract sizeRecordsShare of priced
under $100k00.0%
between $100k and $1M2067%
between $1M and $10M1033%
above $10M00.0%

How long do bidders get to respond to pharmaceuticals tenders in Moldova?

Across the 19 Moldova pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 29 days. A quarter of them allowed 28 days or fewer and a quarter stayed open for more than 32. Not one of them closed within a fortnight of being published, so the window on this market is consistently workable.

How often are pharmaceuticals tenders published in Moldova?

Moldova publishes about 2 notices a month in this category, 30 in the last twelve months. Over the last three years there were 31, spread across 7 separate months of activity since 28 May 2021. October is historically the busiest month. The most recent was published 14 October 2026.

How does Moldova compare with other pharmaceuticals markets?

Among the 45 countries where GlobalGov holds a comparable pharmaceuticals market, Moldova ranks 44th by number of records. The largest is Poland (9,417 records against 36 here). Within Moldova itself, pharmaceuticals is the 5th largest of the 8 procurement categories tracked here.

Where do the Moldova pharmaceuticals records on this page come from?

These 36 records are collected from 2 official sources: TED (35), the World Bank (1). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-11-22.

Open Pharmaceuticals tenders in Moldova

Showing 7 of the 11 notices open in this category today. Openness uses the same definition as the Moldova market page: active, not marked awarded, cancelled, closed or expired, and either closing in the future or published within the last 90 days with no stated closing date.

Moldova – Pharmaceutical products – Procurement of Medicines for the 2027 National Tuberculosis Response Program

Centrul Pentru Achiziții Publice Centralizate În Sănătate$856,095October 02, 2026

Moldova – Pharmaceutical products – Procurement of medicines for the National Program to Combat Viral Hepatitis B, C and D for 2027

Centrul Pentru Achiziții Publice Centralizate În Sănătate$934,179October 01, 2026

Moldova – Pharmaceutical products – Special Program for Supplying Medicines and Medical Devices for Organ Transplantation and Post‑Transplant Patients, 2027

Centrul Pentru Achiziții Publice Centralizate În Sănătate$1.5MSeptember 30, 2026

Moldova – Pharmaceutical products – Procurement of medicines for hemophilia treatment under the National “Rare Diseases Combat” Program for 2027

Centrul Pentru Achiziții Publice Centralizate În Sănătate$2.0MSeptember 30, 2026

Moldova – Pharmaceutical products – Procurement of medicines for the National HIV/AIDS and STI Prevention and Control Program for 2027

Centrul Pentru Achiziții Publice Centralizate În Sănătate$847,622September 28, 2026

Moldova – Pharmaceutical products – Procurement of specially indicated medicines for multiple sclerosis treatment for 2027

Centrul Pentru Achiziții Publice Centralizate În Sănătate$2.1MSeptember 09, 2026

Moldova – Pharmaceutical products – Procurement of Emicizumab for IMSP Mother and Child Institute, 2027

Centrul Pentru Achiziții Publice Centralizate În Sănătate$978,736September 02, 2026
All Moldova procurement →

Other procurement categories in Moldova

Building ConstructionMaintenance & RepairSoftware DevelopmentICT EquipmentVehicles and FleetFood Aid and Nutrition

Pharmaceuticals procurement in other markets

PolandGermanyUnited StatesItalyFranceSpainBulgariaRomaniaCzech RepublicUnited KingdomUkraineDenmark

Never Miss a Moldova Government Contract

Finding Moldova tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new pharmaceuticals opportunity is published there.

Start Free Trial